Comparing Home-Based Telerehabilitation Using the Euleria Home Device to In-Person Rehabilitation for Stroke Survivors A Randomized Crossover Study

What this Trial Is About

Researchers are evaluating whether a home-based telerehabilitation program using the Euleria Homeae device is as effective as conventional outpatient rehabilitation for stroke survivors. The study focuses on motor, cognitive, and language functions in patients with stroke sequelae, aiming to demonstrate non-inferiority of the telerehabilitation approach compared to standard in-person care. Participants are randomly assigned to one of two groups one receives a 5-week in-person rehabilitation program with two 60-minute sessions per week, totaling 10 sessions the other group undergoes a 5-week home-based telerehabilitation program using the Euleria Homeae device, completing 10 hours of therapy at about 20 minutes per session, twice a week. Both treatments are personalized and designed by healthcare professionals. During the study, participants undergo multiple assessments including the Fugl-Meyer Assessment for limbs, cognitive tests like the Oxford Cognitive Screen, and functional evaluations such as the Berg Balance Scale and 10 Meters Walking Test. These tests are administered at baseline, after five weeks of treatment, and four weeks post-treatment. Researchers also measure patient satisfaction and monitor anxiety and depression levels. The entire participation period includes treatment and follow-up assessments over approximately nine weeks.

Effectiveness of a Home-Based Rehabilitation Program in Stroke Survivors Using the Euleria Home® Device